NexImmune • NEXI
NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology.
Ratings
3 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Ms. Kristi Jones$4.5M
Market Cap • 18/04/20242011
(há 13 anos)
2021
(3 years ago)
NASDAQ
Listagem
Gaithersburg
Sede • Maryland50
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
NEXISó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.